Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Utility of CC7 Transfer in Stroke Subtypes — Stella

Home/Stroke, Ischemic/Utility of CC7 Transfer in Stroke Subtypes

View on ClinicalTrials.gov

Recruiting

Back to Stroke, Ischemic trials

Utility of CC7 Transfer in Stroke Subtypes

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Dartmouth-Health, Lebanon, New Hampshire

Key details

Sponsor

Dartmouth-Hitchcock Medical Center

Enrollment target

~95 participants

Started

March 2022

Primary completion

March 2027

Age range

18 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.